Summary
CACNA1A-related disorders are a group of rare genetic conditions that affect the nervous system. They are caused by changes in the CACNA1A gene, which helps control how calcium moves into nerve cells. These disorders can cause a wide range of symptoms, but are all due to differences within the CACNA1A gene.
Symptoms may include:
- Migraine headaches
- Seizures
- Coordination problems
- Unusual eye movements
- Learning and behavioral differences
There is no cure, but treatments and therapies can help with symptoms and improve quality of life.
Description
The CACNA1A gene provides instructions for making a protein that is important for sending signals between nerve cells. Symptoms and severity can vary widely.
CACNA1A-related disorders include:
- Familial Hemiplegic Migraine Type 1 (FHM1): Severe migraine attacks with temporary weakness on one side of the body
- Episodic Ataxia Type 2 (EA2): Repeated attacks of dizziness, poor coordination and sometimes nausea or vomiting
- Spinocerebellar Ataxia Type 6 (SCA6): Gradual worsening of balance and coordination, often starting in adulthood
Signs and Symptoms
Common symptoms include:
- Hemiplegic migraines attacks: Severe headaches with temporary weakness or inability to move one side of the body
- Ataxia: Poor coordination, unsteady walking, slurred speech, and sometimes tremors.
- Seizures
- Neurodevelopmental differences: May include developmental delay, intellectual disability, learning difficulties, autism, and ADHD
- Jiggling eye movements (nystagmus)
Symptoms can be mild or severe. Some symptoms may be present all the time, whereas others lead to sudden attacks.
Many symptoms start in childhood, while others begin in adulthood.
Causes
CACNA1A-related disorders are caused by changes in the CACNA1A gene. Everyone has two copies of the CACNA1A gene. Only one copy of CACNA1A needs to be changed for a person to have symptoms.
These changes can be:
- Inherited: Passed down from a parent
- De novo: Occurring for the first time in a child
The gene change happens randomly and is not caused by anything parents do before or during pregnancy. There are no known environmental causes.
Changes in the CACNA1A gene lead to changes in a protein channel, which is important for signals between nerve cells. Different changes in the gene can cause the channel to be open for either too long or for too little time, which leads to different types of symptoms.
Laboratory Investigations
Diagnosis is based on genetic testing and clinical features.
To diagnose and monitor CACNA1A-related disorders, doctors may use:
- Genetic testing: To identify CACNA1A gene changes
- Brain MRI: To check for changes in the cerebellum (back part of the brain that plays a large role in balance and coordination) or other brain areas
- EEG: To look for abnormal brain activity and seizures
- Neurological exam: To assess coordination, balance, body movements, and eye movements
- Developmental assessments: To measure learning and cognition
These tests are usually done at diagnosis or when families initially have concerns. Some (like EEG or MRI) may be repeated if symptoms change or worsen.
Treatment and Therapies
There is no cure for CACNA1A-related disorders, but treatment focuses on managing symptoms:
- Medications:
- Acetazolamide or 4-aminopyridine for ataxia episodes
- Anti-migraine drugs: To take during migraines or for prevention
- Anti-seizure medications: For epilepsy
- Physical, occupational, and speech therapy: To help with movement, daily skills, and communication
- Supportive care: For feeding, breathing, or swallowing difficulties in severe cases
Treatment plans are personalized. Discuss options with your doctor to learn more about which therapies are best for your child. Without treatment, symptoms like severe migraines, ataxia, or seizures may get worse. Most people need lifelong support from a team of specialists.
Outlook
The outlook depends on the type and severity of the disorder. Some people have mild symptoms and live independently, while others need full-time care.
Most children with developmental and epileptic encephalopathy (changes in the brain leading to severe developmental delay and frequent seizures) have ongoing learning and movement challenges.
The disorders affect daily life, school, and family routines. Families may need to adjust routines and seek support from therapists, teachers, and community resources.
Resources
The links and resources included in this section are solicited directly from the community by the Child Neurology Foundation through a formal submission process. CNF reserves the right to remove entities at any time if information is deemed inappropriate or inconsistent with the mission, vision, and values of CNF. The authors listed on this page have not endorsed the resources or links provided in this section.
Our mission is to find specific treatment options and a cure for CACNA1A patients by building a collaborative network of patients, families, clinicians and scientists that will work together to raise awareness and accelerate the understanding, diagnosis and treatment of CACNA1A-linked diseases.
Our vision is a world free of the debilitating effects of CACNA1A-related disorders.
Our values are guided by the following principles: Collaboration - We believe that partnerships between families, clinicians, and scientists are key to raising awareness of CACNA1A-related disorders and advancing the search for a cure; Purpose-Driven - We understand the urgency of discovering treatment options and the need to fund innovative research that reflects the diversity of the CACNA1A population; Integrity - We realize the importance of transparency and accountability of our organization and the researchers that we fund; Stewardship - We are committed to keeping operating expenses to a minimum to ensure that every donation brings us one step closer to a cure.
Research
ClinicalTrials.gov for CACNA1A (birth to 17 years)
These are clinical trials that are recruiting or will be recruiting. Updates are made daily, so you are encouraged to check back frequently.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. This is a resource provided by the U.S. National Library of Medicine (NLM), which is an institute within the National Institutes of Health (NIH). Listing a study does not mean it has been evaluated by the U.S. Federal Government. Please read the NLM disclaimer for details.
Before participating in a study, you are encouraged to talk to your health care provider and learn about the risks and potential benefits.
For more information about participation in clinical trials, check out our education hub on the topic here.
Family Stories
The CACNA1A Foundation shares patient and family stories to offer hope and guidance for others navigating a CACNA1A diagnosis.
The information in the CNF Child Neurology Disorder Directory is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
References
- Genetics Home Reference. CACNA1A gene [Internet]. Bethesda (MD): National Institutes of Health. Available from: https://ghr.nlm.nih.gov/gene/CACNA1A
- Lipman AR, Fan X, Shen Y, Chung WK. Clinical and genetic characterization of CACNA1A-related disease. Clin Genet. 2022 Oct;102(4):288-295. doi: 10.1111/cge.14180. Epub 2022 Jun 26. PMID: 35722745; PMCID: PMC9458680.
- CACNA1A Foundation [Internet]. CACNA1A Foundation. Available from: https://www.cacna1a.org
- Jen JC. Familial Hemiplegic Migraine. 2001 Jul 17 [updated 2024 Jul 4]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301562.
- Perplexity AI, Inc. Perplexity [Internet]. San Francisco (CA): Perplexity AI, Inc.; 2025 [cited 2025 Oct 24]. Available from: https://www.perplexity.ai
This overview is for general information and is not a substitute for advice from your child's care team.
← Back to the Disorder Directory